MYC and Burkitt lymphoma: We conducted a targeted and quantifiable investigation by employing a transgenic mutation-reporter mouse model containing either a control B-DNA insert or a human H-DNA-forming sequence from a translocation breakpoint hotspot in the c-MYC gene in Burkitt lymphoma, herein referred to as B-DNA and H-DNA mice, respectively52.